ask="2.96"
ask_size="400"
average_daily_volume="35942"
bid="N/A"
bid_size="N/A"
book_value="0.49"
change="+0.07"
change_from_200_day_moving_average="-0.81"
change_from_50_day_moving_average="-0.48"
change_from_52_week_high="-6.15"
change_From_52_week_low="0.38"
change_in_percent="+2.52%"
close="2.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.42"
ebitda="-15.65M"
eps_estimate_current_year="-1.62"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-1.49"
ex_dividend_date="N/A"
float_shares="4342000"
high="3.15"
high_52_weeks="9.00"
last_trade_date="2/10/2017"
last_trade_price="2.85"
last_trade_size="100"
last_trade_time="4:00pm"
low="2.65"
low_52_weeks="2.47"
market_capitalization="23.88M"
moving_average_200_day="3.66"
moving_average_50_day="3.33"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.50"
open="2.74"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-22.05%"
percent_change_from_50_day_moving_average="-14.38%"
percent_change_from_52_week_high="-68.33%"
percent_change_from_52_week_low="+15.38%"
previous_close="2.78"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.63"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="2.29"
stock_exchange="NCM"
symbol="VTGN"
volume="21676"
weeks_range_52="2.47 - 9.00"
